Inpharma 1325 - 16 Feb 2002

■ Three Novartis products have been launched inThailand, reports Scrip. The products are imatinibmesylate [‘Glivec’] for chronic myeloid leukaemia,artemether/lumefantrine [‘Co-Artem’] for falciparummalaria infection in adults and children andverteporfin [‘Visudyne’] for age-related maculardegeneration in patients with predominantly classicsubfoveal choroidal neovascularisation.Three Novartis products launched in Thailand. Scrip : 26, No. 2716, 30 Jan2002 800896393

1

Inpharma 16 Feb 2002 No. 13251173-8324/10/1325-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved